JMP Securities analyst Silvan Tuerkcan reiterated a Buy rating on Solid Biosciences (SLDB – Research Report) today and set a price target of $15.00. The company’s shares closed yesterday at $5 ...
The latest analysts to reiterate their Buy ratings and price targets are Mitchell Kapoor from H.C. Wainwright and Silvan Tuerkcan from JMP Securities. Kapoor sees CRSP rising to $65 per share ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback